Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635

LBPHDelisted Stock  USD 59.98  0.00  0.00%   
Under 52% of Longboard Pharmaceuticals' traders are presently thinking to get in. The analysis of overall sentiment of trading Longboard Pharmaceuticals stock suggests that some investors are interested at this time. Longboard Pharmaceuticals' investing sentiment shows overall attitude of investors towards Longboard Pharmaceuticals.
  
Longboard Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for n

Read at businesswire.com
businesswire News
  

Longboard Pharmaceuticals Fundamental Analysis

We analyze Longboard Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Longboard Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Longboard Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Net Asset

Net Asset Comparative Analysis

Longboard Pharmaceuticals is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.

Longboard Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Longboard Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Longboard Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Longboard Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Longboard Pharmaceuticals Related Equities

GLUEMonte Rosa   6.45   
0%
59.0%
SNSESensei Biotherapeutics   4.65   
0%
43.0%
DSGNDesign Therapeutics   4.34   
0%
40.0%
CELCCelcuity LLC   3.83   
0%
35.0%
STOKStoke Therapeutics   3.36   
0%
31.0%
TILInstil Bio   2.64   
0%
24.0%
CCCCC4 Therapeutics   2.60   
0%
24.0%
NXTCNextCure   2.11   
0%
19.0%
HOWLWerewolf Therapeutics   1.27   
0%
11.0%
MNOVMediciNova   0.46   
0%
4.0%
EWTXEdgewise Therapeutics   0.06   
1.0%
0%
NUVBNuvation Bio   0.37   
3.0%
0%
CSBRChampions Oncology   0.53   
4.0%
0%
MOLNMolecular Partners   2.68   
24.0%
0%
IKNAIkena Oncology   3.73   
34.0%
0%
ASMBAssembly Biosciences   3.80   
35.0%
0%
ANEBAnebulo Pharmaceuticals   10.81   
100.0%
0%
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Consideration for investing in Longboard Stock

If you are still planning to invest in Longboard Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Longboard Pharmaceuticals' history and understand the potential risks before investing.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account